Shandong Xinhua Pharmaceutical Company Limited (SEHK: 719)
Health Care · Pharmaceuticals · CN
HK$5.80
+0.52% today · -19.4% 1Y
Shandong Xinhua Pharmaceutical Company Limited (SEHK: 719) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.24B.
Over the last twelve months the share price has lost 19.4%, trading between 5.18 and 7.64.
Tweenvest scores Shandong Xinhua Pharmaceutical Company Limited across four factors: quality 80/100, value 51/100, growth 53/100, dividend 100/100. Its strongest factor is dividend.
719 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.24B
- Revenue (TTM)
- $1.25B
- P/E
- 16.18
- EPS
- 0.31
- Dividend yield
- 3.03%
- Beta (5Y)
- -0.05
- 52-week high
- HK$7.64
- 52-week low
- HK$5.18
- Avg volume (3M)
- —
- Shares outstanding
- 696.68M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Celltrion Pharm, Inc.KOSDAQ: A068760 | $1.28B | ₩38,800.00 | -3.24% |
| North China Pharmaceutical Company.LtdSHSE: 600812 | $1.27B | CN¥4.98 | +2.05% |
| Zhejiang Garden Biopharmaceutical Co.,Ltd.SZSE: 300401 | $1.25B | CN¥15.41 | -3.45% |
| Zhejiang Xianju Pharmaceutical Co., Ltd.SZSE: 002332 | $1.25B | CN¥8.64 | +0.35% |
| Jiangsu Yahong Meditech Co., Ltd.SHSE: 688176 | $1.23B | CN¥14.60 | -0.88% |
| Changzhou Qianhong Biopharma CO.,LTDSZSE: 002550 | $1.23B | CN¥6.59 | +3.62% |
| Shandong Lukang Pharmaceutical Co.,Ltd.SHSE: 600789 | $1.22B | CN¥7.85 | +4.11% |
| HARBIN GLORIA PHARMACEUTICALS Co., LTDSZSE: 002437 | $1.21B | CN¥3.65 | +4.29% |
Figures last refreshed Oct 4, 2026.